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Abstract: The number of CD4+ T-Iymphocytes, CD4/CD8 ratio, and the number of IL2
W T-Iymphocytes (CD25) were examined in 14 patients with bronchial asthma, and the
results were compared in three different asthma stages: symptom-free stage, wheeze s
tage, and attack stage.
1. The proportion of blood CD4+ T-Iymphocytes was more decreased in patients with
asthma attacks than in those with')ut symptoms. The CD4/CD8 ratio was also more
decreased in patients with attacks than in those without symptoms. However, these
differences were not significant.
2. The proportion of blood activated T cells (I L2R+ cells, CD25) was significantly
increased in patients with attacks than in those without symptoms. The proportion of
activated T cells in 5 asthma patients was 2.9±O.8% in symptom-free stage and 6.6±
1.1 % in attack stage (p<O.OO1).
These findings show that numbers of activated T-Iymphocytes in peripheral blood
were increased during asthma attacks, and this increase suggests the participation of
activated T cells in the pathogenesis of asthma.
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Introduction
Mechanisms causing asthma attacks are
divided into two major phases: early
humoral phase in which release of chemical
mediators play an important role (1,2), and
late cellular phase in which inflammatory cell
infiltration in airways is regarded as a major
factor (3-7). These two major phases can be
observed as immediate asthmatic reactions
OAR) and late asthmatic reaction (LAR)
after bronchial allergen challenge (8,9), Thus,
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the roles of chemical mediators such as
histamine and leukotrienes in the IAR and
inflammatory cells such as lymphocytes,
neutrophils, eosinophils, and basophils in the
LAR have been extensively studied by many
investigators.
Of these inflammatory cells, increasing
attension has been focused on the the roles of
lymphocytes and eosinophils in airways. An
increased number of lymphocytes (10 - 12)
and eosinophils (13,14) in bronchoalveolar
lavage (BAL) fluid has been observed in
patients with asthma, and the increase in
number of lymphocytes is confined to the T
cell population (15). It has been reported
that increased numbers of activated blood T
cells are found during acute exacerbations of
bronchial asthma (16,17). It has been also
found that CD4+ T-Iymphocytes are depleted
in peripheral blood and sequestered in the
lung (18,19). Moreover, a close correlation
has been found between numbers of BAL CD
4+ IL2R+ T cells and numbers of eosinophils
(20).
In the present study, numbers of CD4+
T-Iymphocytes, CD4/CD8 ratio, and numbers
of IL2R+ T-Iymphocytes in peripheral blood
were examined in patients with bronchial
asthma in relation to asthmatic cycle.
Subjects and Methods
The subjects of this study were 14 patients
with bronchial asthma (7 females and 7
males, mean age 60.1 years, range 46 - 77
years). The mean level of serum IgE was 355
IU/mP (range 8-2700 IU/mP). All the sub-
jects were outpatients. Asthma condition of
patients was divided into three stages accord-
ing to their symptoms: 0 symptom-free
stage, 2) wheeze stage in which patients had
occasional wheezing without dyspnea, and 3)
attack stage in which patients had occasional
dyspnea, although they had never required
any urgent treatment.
Analysis of lymphocyt subsets was per-
formed by observing specific binding of
monoclonal antibodies against CD4 (T helper
/inducer), CD8 (T suppressor/cytotoxic),
and CD25 (IL2R)(20). Serum samples for
analysis of lymphocyte subsets were taken in
different conditions of asthma, and the re-
sults were compared among three asthma
stages : symptom-free stage, wheeze stage,
and attack stage.
Serum levels of IgG, IgA and IgM were
measured by turbidometric immunoassay.
Serum IgE levels were estimated by radio-
immunosorbent test (RIST), and the results
were expressed as IU/ mP.
Statistically significant differences of the
mean were assessed using Student't unpaired
t test. The levels of significance were
expresssed as p value.
Results
The level of serum IgE in the subjects was
generally low, and low serum IgE level of less
than 100 IU/mP was found in 9 of the 14
(64.3%) patients. The level of serum IgG was
also generally low: 8 of the 14 (57.18%)
patients showed low serum IgG level less
than 1000 mg/dl (Table O.
The proportion of CD4+ T-Iymphocytes in
peripheral blood was highest in patients
without symptoms (41.3±8.1%) (±SD) and
lowest in those with asthma attacks (35.2 ±
4.3%), suggesting that the proportion of CD
4+ T-Iymphocytes were decreased as symp-
toms of asthma were severe. However, these
differences were not significant among the
three different asthma stages (Fig. O.
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Table 1. Serum Immunoglobulin levels m
patients with bronchial asthma
Age
* ** ** **Name (yr) Sex IgE IgG IgA IgM
A.I. 45 M 78 1080 117 101
Y.K. 45 M 680 920 255 71K.Y. 46 M 321 760 296 51T.N. 50 F 90 1230 160 130T.R. 54 F 120 770 331 101
R.K. 56 F 8 1200 230 66
K.O. 60 M 36 980 272 188
M.T. 61 F 14 1170 242 177
Y.R. 63 F 370 1630 187 169
K.N. 68 F 39 900 143 67
M.T. 71 M 38 870 218 138
A.S. 72 F 88 940 126 73
T.R. 74 M 63 1250 328 99S.F. 77 M 2700 950 238 80
* **Serum 19E levels, lU/ml. Serum IgG, IgA and 19M levels,
mgldl.
•
•
50 -
attacks (dyspnea). The CD4/CD8 ratio was
also decreased as asthma symptoms were
severe, although these differences were not
significant among the three stages (Fig. 2).
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Fig. 2. CD4/CD8 ratio m patients with
bronchial asthma m relation to
asthmatic cycle. Vertical columns
represent the mean for each asthma
stage. A : symptom-free stage; B :
wheeze stage; C : attack stage.
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The CD4/CD8 ratio was 2.4 ± 1.06 in pa-
tients without symptoms, 1.75±0.69 in those
with wheezes, and 1.59 ± 0.5 in those with
Fig. 1. The proportion of CD4+ T-Iymphocy-
tes III peripheral blood of patients
with bronchial asthma in relation to
asthmatic cycle. Vertical columns
represent the mean for each asthma
stage. A: symptom-free stage; B :
wheeze stage; C : attack stage.
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The proportion of IL2R+ T-Iymphocytes
was 3.5±1.1% in patients without symptoms,
3.8±1.1% in those with wheezes, and 5.8± 1.
9% in those with attacks, as shown in Fig. 3.
The proportion of IL2R+ T-Iymphocytes was
significantly higher in patients with attacks
than in those without symptoms (p<O.Ol) or
with wheezes (p<0.02). The proportion of
IL2R+T-Iymphocytes was compared between
the two different stages, symptom-free and
attack stages of each subject with asthma.
Blood samples in two different stages could
be taken in 5 subjects. An increased propor-
tion of IL2R+ T cells was found in attack
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stage of all 5 subjects. The proportion of IL2
R+ T-lymphocytes in attack stage was 6.6±1.
1% in these 5 subjects, which was signifi-
cantly higher than that in symptom-free
stage (2.9±0.8%) (p<O.OOl) (Fig. 4).
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Fig. 3. The proportion of IL2R+ T-Iymphocy-
tes in patients with bronchial asthma
in relation to asthmatic cycle. Verti-
cal columns represent the mean for
each asthmsa stage. A: symptom-
free stage; B : wheeze stage; C
attack stage. *P<O.Ol ; **P<0.02.
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Fig. 4. The proportion of IL2R+ T-lymphocy-
tes in symptom-free stage and attack
stage of each patient with asthma. A
: symptom-free stage ; C : attack
stage. *P<O.OOl.
Discussion
Airway inflammation has been noted as a
major factor related to the pathogenesis of
asthma. The roles of various inflammatory
cells have been studied by analyzing humoral
an cellular events in bronchoalveolar lavage
(BAL) fluid (3-7, 10-14, 21, 22). The roles of
inflammatory cells can be evaluated by acti-
vation of these cells. Regarding lymphocytes
in BAL fluid, increased numbers of BAL
lymphocytes have been observed in patients
with bronchial asthma (10-12), and this
increase in BAL lymphocyte number is clari-
fied to be due to T cell population (15).
These findings suggest that T lymphocytes
play an important role in the late cellular
phase of asthma. Furthermore, Walker et al
reproted that BAL lymphocytosis consisted of
increased numbers of both CD4+ and CD8+ T
cells, and that these T cell populations ex-
pressed elevated levels of T cell activation
markers Cinterleukin-2 receptor: CD25, HLA-
Dr, and very late activation antigen). They
also concluded that there was a close correla-
tion between numbers of BAL CD4+ IL2R+ T
cells and numbers of BAL eosinophils, and
that the numbers of activated T cells and
eosinophils were related to the severity of
asthma (20). The results show that activa-
tion of T lymphocytes is closely related to
inflammatory cell infiltration.
Regarding blood lymphocytes, it has been
reported that CD4+ T-lymphocytes are de-
creased and sequestered in the lung after
bronchial allergen challlenge (18, 19). In the
present study, numbers of CD4+ T-Iymphocy-
tes in peripheral blood were compared in
three different asthma stages, symptom-free
stage, wheeze stage, and attack stage. The
results demonstrated that the proportion of
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CD4+ T-lymphocytes was more decreased in
patients with attacks than in those without
symptoms. The CD4/CD8 ratio was also
decreased as the symptoms of asthma were
severe. Decreased number of blood CD4+
T-lymphocytes in patients with attacks seems
to be in qgreement with the results reported
by Gelblich et al (19). However, the differ-
ence in this study was not significant.
The proportion of activated T-lymphocytes
(IL2R+ cells) were significantly increased in
patients with attacks than in those without
symptoms. The results show that the propor-
tion of activated T cells is increased during
asthma ttacks, and this increase suggest that
activated T cells participate in the pathogene-
sis of asthma.
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気管支鴨息14例を対象に,末梢血CD4十リンパ
球の頻度,CD4/CD8比およびIL2R+Tリンパ球
の頻度について,喋息発作との関連のもとに検討
を加えた｡
1.CD4十リンパ球の頻度は,非発作時の症例で
最も高く,瑞鳴のみの症例,発作の見られる症
例へと順次低くなる傾向が見られたが,推計
学的には有意の差は見られなかった｡CD4/C
D8比も同様に,非発作時に最も高く,発作を有
する症例では非発作時に比べ低い値を示した
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が,推計学的には有意の差は見られなかった｡
2.IL2R+Tリンパ球 (activatedTリンパ球)の
頻度は,非発作時の症例で最も低く (3.5±1.1
%),鴨場のみをともなう症例 (3.8±1.1%),
発作の見られる症例 (5.8±1.9%)へと順次高
くなる傾向を示し,発作のある症例では,非発
作および瑞鳴のみの症例に比べ有意に高い値
を示した｡また,非発作時と発作のある時期にI
L2R+Tリンパ球を観察し得た5症例では,罪
発作時2.9±0.8%,発作のある時期6.6±1.1%
であり,発作のある時期に有意の高値を示し
た (p<0.001)0
これらの結果は,発作のある時期にはacti-
VatedTリンパ球の頻度が増加すること,そして,
この増加はactivatedTリンパ球が喋息発作の病
態と密接な関連を有していることを示唆するも
のと考えられた｡
キーワード:CD4+リンパ球,CD4/CD8比,IL2
氏+Tリンパ球,気管支瑞息
